Benralizumab and the integrated management of co-morbid severe eosinophilic asthma with chronic rhinosinusitis with nasal polyps Review

sustainable development goals

publication date

  • April 1, 2025

webpage

published in

keywords

  • CRSwNP
  • benralizumab
  • biologics
  • eosinophilia
  • severe eosinophilic asthma

volume

  • 15

issue

  • 4